Zoladex (Goserelin) vs CMF as adjuvant therapy in pre-/perimenopausal node-positive breast cancer. Preliminary efficacy results from the ZEBRA Study (ZEBRA - Zoladex Early Breast Cancer Research Association - Trialists Group). - Namer,M. (Ann Oncol, 2000)